Ashland updates fiscal 2026 outlook as Hopewell delays cut Q2 Adjusted EBITDA 9%
Ashland reported second-quarter fiscal 2026 sales of $482 million, up one percent, but Adjusted EBITDA fell nine percent to $98 million and net income dropped to $16 million from $31 million. The company updated its full-year fiscal 2026 guidance to sales of $1,835 million to $1,870 million and Adjusted EBITDA of $385 million to $400 million, citing a slower-than-expected productivity ramp at its Hopewell facility.
Key points
- Q2 sales $482 million, up one percent; pricing declined two percent
- Q2 Adjusted EBITDA $98 million, down nine percent from $108 million; net income $16 million vs. $31 million
- Full-year fiscal 2026 Adjusted EBITDA guidance $385 million to $400 million; sales guidance $1,835 million to $1,870 million
- Fiscal 2026 manufacturing optimization savings expectations reduced by approximately $10 million to $12 million
The filing
Written by AI on Nov 8, 2026, 1:39 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 28, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.